Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Calidi Biotherapeutics gets NYSE compliance warning but stock surprises

Paramount Skydance announced on Friday that it will relocate the listing of its Class B common stock from Nasdaq to the New York Stock Exchange (NYSE) starting October 6. Trading on Nasdaq is set to conclude by October 5. The two major US exchanges, Nasdaq and the NYSE, have historically competed for dominance, with Nasdaq predominantly featuring tech stocks and the NYSE housing major industrial and financial institutions. This rivalry intensified during the dot-com boom of the late 1990s.

Companies often shift their listing venues in response to better alignment with an exchange's investor base, technology offerings, or services, as well as to reduce listing and compliance costs. Paramount is anticipated to finalize its $110 billion Warner Bros. deal soon, following its resolution of a legal dispute with California-led state governments and the Hollywood Writers Guild earlier this week.

Moreover, October 5 has been designated as the record date for distributing warrants to eligible holders of Paramount's Class B common stock as part of its Warner Bros. agreement.

Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Read the original at seekingalpha.com →

More in Finance & Markets

Así gestiona su fortuna Jensen Huang

Además de controlar cerca del 4% de Nvidia, el empresario cuenta con una cartera de propiedades de lujo en California y Hawái, y capitanea operaciones a través del brazo inversor de la tecnológica.

More from Friday 25 September →